PureTech News

Press releases
Press Releases - 2022-12-22
Other
Internal Program - LYT-100
PureTech Provides End of Year Report on Key Progress
Continue
Press Releases - 2022-12-19
Seaport
PureTech's LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerability and GABAA Receptor Target Engagement in Healthy Volunteers
Continue
Press Releases - 2022-12-13
Other
PureTech to Present at 41st Annual J.P. Morgan Healthcare Conference
Continue
Press Releases - 2022-12-12
Gallop Oncology – LYT-200
PureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual Meeting
Continue
Press Releases - 2022-12-07
Vor
PureTech Founded Entity Vor Bio Announces First AML Patient Successfully Transplanted with its Investigational Trem-cel (VOR33) and Tolerated Mylotarg™
Continue
Press Releases - 2022-11-30
Seaport
PureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech's Glyph™ Platform
Continue
Press Releases - 2022-11-17
Other
PureTech to Present at Two Upcoming Investor Conferences
Continue
Press Releases - 2022-11-09
Other
PureTech to Present at the Jefferies London Healthcare Conference
Continue
Press Releases - 2022-11-02
Other
Gelesis
PureTech Founded Entity Gelesis Announces Two Presentations at ObesityWeek 2022
Continue
Press Releases - 2022-11-01
Other
PureTech to Present at the Credit Suisse 31st Annual Healthcare Conference
Continue
Displaying 71 - 80 of 189

Sign up for email alerts

To receive news as it is released, please sign up.

@PureTechH